Pharmacological Targeting Strategies of Pancreatic Beta Cells for Type 2 Diabetes Therapy

    January 2025 in “ il Diabete ”
    Giuseppina Biondi, Nicola Marrano, Anna Borrelli, Martina Rella, Annalisa Natalicchio, Francesco Giorgino
    TLDR Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.
    The document discusses targeted drug delivery strategies to pancreatic beta-cells as a promising therapeutic option for type 2 diabetes (T2D). It highlights the potential to improve drug efficacy while reducing doses and side effects by specifically inducing drug expression in beta-cells. The paper reviews available drug carriers, peptides for active targeting, and suitable administration routes to effectively direct drugs to beta-cells.
    Discuss this study in the Community →